PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148865
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148865
Prothrombin Complex Concentrate Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of Prothrombin Complex Concentrate (PCC) Market
The global Prothrombin Complex Concentrate (PCC) Market size was valued at USD 2.57 billion in 2025. The market is projected to grow from USD 2.84 billion in 2026 to USD 6.34 billion by 2034, reflecting a CAGR of 10.56% during the forecast period. North America dominated the global Prothrombin Complex Concentrate Market with a 44.0% share in 2025. Increasing demand for rapid anticoagulation reversal therapies, the growing use of warfarin, rising bleeding disorders, and improved healthcare infrastructure are supporting market expansion.
Prothrombin complex concentrate is a plasma-derived or recombinant-related coagulation factor replacement therapy containing clotting factors used to rapidly restore blood coagulation. PCC is widely utilized for emergency reversal of vitamin K antagonist anticoagulation, particularly in patients experiencing severe or life-threatening bleeding. Compared with Fresh Frozen Plasma (FFP), PCC provides advantages such as lower administration volume, faster preparation, and reduced dependence on blood-group matching and thawing.
PROTHROMBIN COMPLEX CONCENTRATE MARKET TRENDS
A major Prothrombin Complex Concentrate Market trend is the expansion of plasma collection and manufacturing capabilities. Leading manufacturers are increasing investments in plasma centers, production facilities, and distribution networks to strengthen the availability of plasma-derived therapies. Strategic acquisitions and collaborations are also helping companies expand their geographic presence and improve supply capabilities.
The COVID-19 pandemic increased attention toward plasma-derived medicines and emergency coagulation therapies. Hospitals increased procurement of essential blood and plasma products, supporting demand for PCC. Continued development of four-factor PCC products is also expected to create new opportunities across developed and emerging healthcare markets.
DRIVING FACTORS
Rapid Adoption of Vitamin K Antagonists to Drive Market Growth
The increasing use of vitamin K antagonists, particularly warfarin, is an important factor driving the PCC Market. Although anticoagulants are essential for preventing thromboembolic events, excessive anticoagulation can result in serious bleeding requiring urgent reversal. PCC provides rapid replacement of deficient clotting factors, making it an important treatment option for emergency warfarin reversal.
Advantages of PCC over Alternative Reversal Therapies
PCC offers several operational and clinical advantages over Fresh Frozen Plasma. It can be administered in substantially smaller volumes and does not require the same preparation processes associated with plasma transfusion. Faster administration is particularly valuable in emergency departments, surgical settings, and critical-care environments.
RESTRAINING FACTORS
Risk of Thrombotic Complications to Limit Market Expansion
The risk of thrombotic complications remains a major restraint for the Prothrombin Complex Concentrate Industry. PCC administration can be associated with adverse events including venous thromboembolism, myocardial infarction, microvascular thrombosis, and disseminated intravascular coagulation. Concerns regarding these safety risks can influence physician preference and treatment decisions.
SEGMENTATION ANALYSIS
By Product Type: The market is divided into 3-factor PCC and 4-factor PCC. The 4-factor PCC segment accounted for the leading position, supported by products such as Kcentra and Beriplex and their use in urgent anticoagulation reversal. The 4-factor PCC segment generated USD 945.2 million in 2025.
By Application: The market is segmented into acquired coagulation factor deficiency and congenital coagulation factor deficiency. Acquired coagulation factor deficiency represents the leading application due to the increasing number of anticoagulant-associated bleeding cases and surgical requirements.
By End User: The market includes hospitals and ambulatory surgery centers, specialty clinics, and others. Hospitals and ASCs dominated the market with a 74.2% share in 2025, owing to the high use of PCC in emergency and surgical settings.
REGIONAL ANALYSIS
North America held the dominant position in the global market in 2025, supported by advanced healthcare infrastructure, regulatory support for four-factor PCC, and strong adoption of emergency anticoagulation reversal therapies.
Europe is expected to witness substantial growth due to increasing adoption of PCC, favorable reimbursement conditions, and expanding availability of plasma-derived products.
Asia Pacific is projected to experience significant growth, driven by increasing warfarin prescriptions, improving healthcare infrastructure, rising awareness of bleeding disorder treatments, and expanding access to essential therapies in countries such as China and Japan. The Japan market is expected to reach USD 40.6 million in 2025, while China is projected to register strong growth during the forecast period.
The Middle East, Africa, and Latin America are also expected to expand as healthcare spending increases and distribution networks for specialized coagulation therapies improve.
KEY INDUSTRY PLAYERS
Major companies operating in the Prothrombin Complex Concentrate Market include Grifols, S.A., CSL Behring, Octapharma AG, Sanquin, Kedrion S.p.A., China Biologic Products Holdings, Inc., and Takeda Pharmaceutical Company Limited.
KEY INDUSTRY DEVELOPMENTS
Key industry developments include strategic plasma-center acquisitions, international expansion of PCC products, and increased investment in plasma-derived therapeutic manufacturing. Grifols expanded its plasma-related operations through strategic transactions, while CSL Behring strengthened its international presence through the launch of Kcentra in Japan.
MARKET OUTLOOK AND OPPORTUNITIES
The Prothrombin Complex Concentrate Market Outlook remains positive as healthcare providers increasingly prioritize rapid treatment for life-threatening bleeding. Expansion of plasma collection infrastructure, improved product availability, increasing anticoagulant utilization, and broader adoption of four-factor PCC are expected to create significant Market Opportunities through 2034.
CONCLUSION
The global Prothrombin Complex Concentrate Market is positioned for strong long-term expansion, increasing from USD 2.57 billion in 2025 to USD 2.84 billion in 2026 and reaching USD 6.34 billion by 2034. Growing demand for rapid anticoagulation reversal, increasing use of warfarin, expanding plasma-derived product manufacturing, and rising healthcare investment will remain important growth factors. Although thrombotic safety concerns may restrict adoption in some cases, continued clinical development, regulatory support, and improved access to PCC therapies are expected to strengthen the industry's overall Market Growth, Market Size, Market Share, Market Trends, Market Forecast, Market Insights, Market Analysis, and Market Outlook through 2034.
Unit Value (USD million)
By Product Type
- 3-factor
- 4-factor
By Application
- Acquired Coagulation Factor Deficiency
- Congenital Coagulation Factor Deficiency
By End User
- Hospital & Ambulatory Surgical Centers
- Specialty Clinics
- Others
By Geography
- North America (the U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- The Middle East& Africa (South Africa, GCC, and Rest of the Middle East & Africa)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics - Global PCC Market
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Prevalence of Coagulation Factor Deficiency - For Key Countries
- 4.2. Recent Industry Developments - Partnerships, Mergers & Acquisitions
- 4.3. Regulatory Scenario - For Key Countries
- 4.4. Analysis in Relation to Alternatives to PCC
- 4.5. Global PCC Market: Reimbursement Scenario & Key Industry Trends
5. Global Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast - By Product
- 5.2.1. 3-factor PCC
- 5.2.2. 4-factor PCC
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Acquired coagulation factor deficiency
- 5.3.2. Congenital coagulation factor deficiency
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Hospitals
- 5.4.2. Ambulatory Surgical Centers
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By Geography
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast - By Product
- 6.2.1. 3-factor PCC
- 6.2.2. 4-factor PCC
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Acquired coagulation factor deficiency
- 6.3.2. Congenital coagulation factor deficiency
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Hospitals
- 6.4.2. Ambulatory Surgical Centers
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast - By Product
- 7.2.1. 3-factor PCC
- 7.2.2. 4-factor PCC
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Acquired coagulation factor deficiency
- 7.3.2. Congenital coagulation factor deficiency
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Hospitals
- 7.4.2. Ambulatory Surgical Centers
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast - By Product
- 8.2.1. 3-factor PCC
- 8.2.2. 4-factor PCC
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Acquired coagulation factor deficiency
- 8.3.2. Congenital coagulation factor deficiency
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Hospitals
- 8.4.2. Ambulatory Surgical Centers
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of APAC
9. Latin America Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast - By Product
- 9.2.1. 3-factor PCC
- 9.2.2. 4-factor PCC
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Acquired coagulation factor deficiency
- 9.3.2. Congenital coagulation factor deficiency
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Hospitals
- 9.4.2. Ambulatory Surgical Centers
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of LATAM
10. Middle East & Africa Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast - By Product
- 10.2.1. 3-factor PCC
- 10.2.2. 4-factor PCC
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Acquired coagulation factor deficiency
- 10.3.2. Congenital coagulation factor deficiency
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Hospitals
- 10.4.2. Ambulatory Surgical Centers
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. South Africa
- 10.5.2. GCC
- 10.5.3. Rest of MEA
11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2025)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis - Major Players
- 11.5. Company Profiles
- 11.5.1. Grifols SA
- 11.5.1.1. Overview,
- 11.5.1.2. Product offerings,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. Strategies,
- 11.5.1.6. Financials (based on availability)
- 11.5.2. CSL Behring
- 11.5.2.1. Overview,
- 11.5.2.2. Product offerings,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. Strategies,
- 11.5.2.6. Financials (based on availability)
- 11.5.3. Octapharma AG
- 11.5.3.1. Overview,
- 11.5.3.2. Product offerings,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. Strategies,
- 11.5.3.6. Financials (based on availability)
- 11.5.4. Sanquin
- 11.5.4.1. Overview,
- 11.5.4.2. Product offerings,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. Strategies,
- 11.5.4.6. Financials (based on availability)
- 11.5.5. Shire
- 11.5.5.1. Overview,
- 11.5.5.2. Product offerings,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. Strategies,
- 11.5.5.6. Financials (based on availability)
- 11.5.6. Kedrion S.p.A
- 11.5.6.1. Overview,
- 11.5.6.2. Product offerings,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. Strategies,
- 11.5.6.6. Financials (based on availability)
- 11.5.7. China Biologic Products Holdings, Inc.
- 11.5.7.1. Overview,
- 11.5.7.2. Product offerings,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. Strategies,
- 11.5.7.6. Financials (based on availability)
- 11.5.1. Grifols SA
12. Strategic Recommendations
List of Tables
- Table 01 Recent Industry Developments: Key Mergers & Acquisitions, 2025
- Table 02 Alternatives to PCC Treatment
- Table 03 Prevalence of Coagulation Factor Deficiency, By Country and Coagulation Factors, 2025
- Table 04 Global Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
- Table 05 Global Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
- Table 06 Global Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 07 Global Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
- Table 08 North America Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
- Table 09 North America Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
- Table 10 North America Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 11 North America Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Country, 2021-2034
- Table 12 Europe Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
- Table 13 Europe Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
- Table 14 Europe Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 15 Europe Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2034
- Table 16 Asia Pacific Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
- Table 17 Asia Pacific Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
- Table 18 Asia Pacific Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 19 Asia Pacific Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2034
- Table 20 Latin America Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
- Table 21 Latin America Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
- Table 22 Latin America Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 23 Latin America Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2034
- Table 24 Middle East & Africa Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
- Table 25 Middle East & Africa Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
- Table 26 Middle East & Africa Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 27 Middle East & Africa Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Country/ Sub-region, 2021-2034
List of Figures
- Figure 01 Global Prothrombin Complex Concentrate (PCC) Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034
- Figure 02 Prevalence of Coagulation Factor Disorders, By Key Countries, 2025
- Figure 03 Global Prothrombin Complex Concentrate Market Value Share (%), by Product, 2025 & 2034
- Figure 04 Global Prothrombin Complex Concentrate Market Forecast (US$ Mn), by 3-Factor PCC, 2021-2034
- Figure 05 Global Prothrombin Complex Concentrate Market Forecast (US$ Mn), by 4-Factor PCC, 2021-2034
- Figure 06 Global Prothrombin Complex Concentrate Market Value Share (%), by Application, 2025 & 2034
- Figure 07 Global Prothrombin Complex Concentrate Market Forecast (US$ Mn), by Acquired Coagulation Factor Deficiency, 2021-2034
- Figure 08 Global Prothrombin Complex Concentrate Market Forecast (US$ Mn), by Congenital Coagulation Factor Deficiency, 2021-2034
- Figure 09 Global Prothrombin Complex Concentrate Market Value Share (%), by End User, 2025 & 2034
- Figure 10Global Prothrombin Complex Concentrate Market Forecast (US$ Mn), by Hospitals, 2021-2034
- Figure 11Global Prothrombin Complex Concentrate Market Forecast (US$ Mn), by Ambulatory Surgical Centers, 2021-2034
- Figure 12 Global Prothrombin Complex Concentrate Market Forecast (US$ Mn), by Others, 2021-2034
- Figure 13Global Prothrombin Complex Concentrate Market Value Share (%), by Region, 2025 & 2034
- Figure 14 North America Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Product, 2025 & 2034
- Figure 15 North America Prothrombin Complex Concentrate Market Value Share (%), by Product,2025
- Figure 16 North America Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Application, 2025 & 2034
- Figure 17 North America Prothrombin Complex Concentrate Market Value Share (%), by Application, 2025
- Figure 18 North America Prothrombin Complex Concentrate Market Value Share (US$ Mn), by End User, 2025 & 2034
- Figure 19 North America Prothrombin Complex Concentrate Market Value Share (%), by End User, 2025
- Figure 20 North America Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Country, 2025 & 2034
- Figure 21 North America Prothrombin Complex Concentrate Market Value Share (%), by Country, 2025
- Figure 22 Europe Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Product, 2025 & 2034
- Figure 23 Europe Prothrombin Complex Concentrate Market Value Share (%), by 2025
- Figure 24 Europe Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Application, 2025 & 2034
- Figure 25 Europe Prothrombin Complex Concentrate Market Value Share (%), by Application, 2025
- Figure 26 Europe Prothrombin Complex Concentrate Market Value Share (US$ Mn), by End User, 2025 & 2034
- Figure 27Europe Prothrombin Complex Concentrate Market Value Share (%), by End User, 2025
- Figure 28 Europe Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Country/Sub-region, 2025 & 2034
- Figure 29 Europe Prothrombin Complex Concentrate Market Value Share (%), by Country/Sub-region, 2025
- Figure 30 Asia Pacific Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Product, 2025 & 2034
- Figure 31 Asia Pacific Prothrombin Complex Concentrate Market Value Share (%), by Product, 2025
- Figure 32 Asia Pacific Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Application, 2025 & 2034
- Figure 33 Asia Pacific Prothrombin Complex Concentrate Market Value Share (%), by Application, 2025
- Figure 34 Asia Pacific Prothrombin Complex Concentrate Market Value Share (US$ Mn), by End User, 2025 & 2034
- Figure 35Asia Pacific Prothrombin Complex Concentrate Market Value Share (%), by End User, 2025
- Figure 36 Asia Pacific Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Country/Sub-region, 2025 & 2034
- Figure 37 Asia Pacific Prothrombin Complex Concentrate Market Value Share (%), by Country/Sub-region, 2025
- Figure 38 Latin America Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Product, 2025 & 2034
- Figure 39 Latin America Prothrombin Complex Concentrate Market Value Share (%), by Product, 2025
- Figure 40 Latin America Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Application, 2025 & 2034
- Figure 41 Latin America Prothrombin Complex Concentrate Market Value Share (%), by Application, 2025
- Figure 42 Latin America Prothrombin Complex Concentrate Market Value Share (US$ Mn), by End User, 2025 & 2034
- Figure 43 Latin America Prothrombin Complex Concentrate Market Value Share (%), by End User, 2025
- Figure 44 Latin America Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Country/Sub-region, 2025 & 2034
- Figure 45 Latin America Prothrombin Complex Concentrate Market Value Share (%), by Country/Sub-region, 2025
- Figure 46 Middle East & Africa Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Product, 2025 & 2034
- Figure 47 Middle East & Africa Prothrombin Complex Concentrate Market Value Share (%), by Product, 2025
- Figure 48 Middle East & Africa Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Application, 2025 & 2034
- Figure 49 Middle East & Africa Prothrombin Complex Concentrate Market Value Share (%), by Application, 2025
- Figure 50 Middle East & Africa Prothrombin Complex Concentrate Market Value Share (US$ Mn), by End User, 2025 & 2034
- Figure 51 Middle East & Africa Prothrombin Complex Concentrate Market Value Share (%), by End User, 2025
- Figure 52 Middle East & Africa Prothrombin Complex Concentrate Market Value Share (US$ Mn) by Country/Sub-region, 2025 & 2034
- Figure 53 Middle East & Africa Prothrombin Complex Concentrate Market Value Share (%), by Country/Sub-region, 2025
- Figure 54 Global PCC Market Share Analysis (%), By Company, 2025
- Figure 55 Comparison Analysis of Key Players, 2025
